
Building a Northeast Asia Clinical Network Across Korea, China, and JapanC&R Research is accelerating its transformation into an AI-driven data CRO while expanding its multinational clinical trial portfolio.Supported by its integrated clinical network across Korea, China, and Japan, the company continues to strengthen its growth potential and enhance operational efficiency.For more details, please refer to the link below.Read the text | Ref: MoneyToday
2026-07-23
Accelerating Global CRO Expansion with Networks Across China, Japan, and Southeast AsiaC&R Research is expanding its CRO network across China, Japan, and Southeast Asia to strengthen its presence in the Asian clinical research market.By enhancing its global clinical trial capabilities and regional collaboration,the company is accelerating its strategy to become a leading Asia-focused global CRO.For more details, please refer to the link below.Read the text | Ref: Consumertimes
2026-07-22
[Interview] Byungkwan Park, Head of CDSA DivisionC&R Research is accelerating its transformation into a data-driven CRO positioned to lead the global marketby building an AI- and data-powered clinical operations framework centered around its CDSA Division.By advancing AI-enabled workflow innovation and data-driven decision-making,the company is enhancing the efficiency and quality of clinical operations.For more details, please refer to the link below.Read the text | Ref: THE BIO
2026-07-20
Partnership with Japanese CRO Strengthens Regional Capabilities and Accelerates Expansion Across AsiaC&R Research has acquired an equity stake in EPS International Korea Ltd., the Korean subsidiary of Japan's EPS Group, marking a significant step toward establishing an integrated clinical development platform spanning Korea, China, and Japan.Through this acquisition, C&R Research strengthens its collaborative foundation with a leading Japanese CRO and further accelerates its expansion into the broader Asian clinical research market.For more details, please refer to the link below.Read the text | Ref: Hankyung
2026-07-13
July 29 Webinar to showcase research using hospital CDW and HIRA DataC&R Research will host its 7th webinar on July 29 under the theme, "Exploring RWD∙RWE in Database-Based PMS∙OS Studies: How Far Can We Go?"The webinar will explore the use of hospital CDW and HIRA data in post-marketing research.For more details, please refer to the link below.Read the text | Ref: Pharmnews
2026-07-08
Combining AI-Driven CRO Capabilities to Explore New Business OpportunitiesC&R Research has signed an MOU with Taimei Intelligence R&D to expand its global clinical research business.Leveraging Taimei Group's global network, the two companies will conduct local roadshows and pursue new global clinical trial opportunities.By combining AI-driven capabilities with CRO expertise, they aim to build a two-way platform connecting the Chinese and global markets while jointly developing new business opportunities.For more details, please refer to the link below.Read the text | Ref: Newspim
2026-07-01